Show simple item record

dc.contributor.authorSadigh-Eteghad, S
dc.contributor.authorMajdi, A
dc.contributor.authorTalebi, M
dc.contributor.authorMahmoudi, J
dc.contributor.authorBabri, S
dc.date.accessioned2018-08-26T07:43:12Z
dc.date.available2018-08-26T07:43:12Z
dc.date.issued2015
dc.identifier.urihttp://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/47959
dc.description.abstractNicotinic acetylcholine receptors (nAChRs) seem to play an integral role in the progress and/or prevention of Alzheimer's diseases (AD). Functional abnormalities and problems in biogenesis and trafficking of nAChRs are two major culprits in AD; on the other hand, chaperones modulate post-translational changes in nAChRs. Moreover, they indirectly regulate nAChRs by controlling AD-related proteins such as tau and amyloid beta (A beta). In this review, we go through recent studies which are showing that chaperones modulate the expression of nAChRs in a subtype-specific manner and explain how AD progress is affected by nAChRs chaperoning. (C) 2015 Elsevier B.V. All rights reserved.
dc.language.isoEnglish
dc.relation.ispartofEUROPEAN JOURNAL OF PHARMACOLOGY
dc.subjectRegulation
dc.subjectNicotinic acetylcholine receptors
dc.subjectAlzheimer
dc.subjectChaperone
dc.titleRegulation of nicotinic acetylcholine receptors in Alzheimer's disease: A possible role of chaperones
dc.typeReview
dc.citation.volume755
dc.citation.spage34
dc.citation.epage41
dc.citation.indexWeb of science
dc.identifier.DOIhttps://doi.org/10.1016/j.ejphar.2015.02.047


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record